Pure Global AI
NCT06384040Recruiting

Immuno-based Profiling of knEe OA Patients to Predict reSponse to Regenerative Treatment

Istituto Clinico HumanitasClinicalTrials.govprocedure
Study focus
Disease/Condition
Osteoarthritis, Knee
Drug/Device/Intervention
platelet-rich plasma knee injection
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
Istituto Clinico Humanitas
Location
Rozzano, Italy
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2021
End date
Oct 30, 2024
Enrollment
105 participants
Primary outcome

knee OA patients focusing on changes in Wnt and IL1-ß signalling and PTX3 expression

Summary

Osteoarthritis (OA) is a highly prevalent degenerative musculoskeletal disease and a major
 cause of chronic disability worldwide. Its multifactorial origin contributes to determine the
 heterogeneous phenotypes and one unmet need is the lack of biomarkers to predict the
 individual response. Platelet-rich-plasma (PRP) injection is a minimally invasive autologous
 blood-derived approach for which we plan to define specific knee profiles predictive of
 response. We will take advantage of a unique multidisciplinary approach aimed at analysing
 clinics, imaging, and biomarkers of associated with clinical response. We will focus on
 inflammatory (Wnt system, IL1 pathway, PTX3) and antioxidant (primarily, DPP3/Keap1/Nrf2)
 pathways. We foresee that our results will allow a better allocation of immunomodulatory and
 regenerative therapies for a personalized approach in knee OA thus maximising the
 effectiveness of the healthcare allocation.

ICD-10 classifications
Chronic instability of kneeInjuries to the knee and lower legGonarthrosis [arthrosis of knee]Dislocation, sprain and strain of joints and ligaments of kneeSprain and strain of other and unspecified parts of knee
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06384040
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06384040 through Pure Global AI's free database. This phase not specified trial is sponsored by Istituto Clinico Humanitas and is currently Recruiting. The study focuses on Osteoarthritis, Knee. Target enrollment is 105 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.